Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Return on Sales: 2014-2017

Historic Return on Sales for Soleno Therapeutics (SLNO) over the last 3 years, with Jun 2017 value amounting to -4.46%.

  • Soleno Therapeutics' Return on Sales rose 852.00% to -4.46% in Q2 2017 from the same period last year, while for Jun 2017 it was -4.46%, marking a year-over-year increase of 852.00%. This contributed to the annual value of 761.26% for FY2024, which is N/A change from last year.
  • As of Q2 2017, Soleno Therapeutics' Return on Sales stood at -4.46%, which was up 7.07% from -4.80% recorded in Q1 2017.
  • In the past 5 years, Soleno Therapeutics' Return on Sales ranged from a high of 6.56% in Q3 2015 and a low of -20.02% during Q4 2015.
  • Moreover, its 3-year median value for Return on Sales was -6.00% (2016), whereas its average is -5.94%.
  • As far as peak fluctuations go, Soleno Therapeutics' Return on Sales tumbled by 2,227bps in 2015, and later spiked by 1,282bps in 2016.
  • Quarterly analysis of 4 years shows Soleno Therapeutics' Return on Sales stood at 2.25% in 2014, then tumbled by 2,227bps to -20.02% in 2015, then spiked by 1,282bps to -7.20% in 2016, then skyrocketed by 852bps to -4.46% in 2017.
  • Its Return on Sales stands at -4.46% for Q2 2017, versus -4.80% for Q1 2017 and -7.20% for Q4 2016.